Literature DB >> 30029937

Mesenchymal stem cells up-regulate the invasive potential of prostate cancer cells via the eotaxin-3/CCR3 axis.

Yukako Ishida1, Akira Kido2, Manabu Akahane3, Shingo Kishi4, Shinji Tsukamoto5, Hiromasa Fujii4, Kanya Honoki4, Yasuhito Tanaka4.   

Abstract

This study aimed to clarify the role of mesenchymal stem cells (MSCs) as a component of the cancer microenvironment. We investigated the homing-related chemokine expression levels of MSCs treated with a prostate cancer cell line (PC-3) -conditioned medium. Among several homing chemokines, an antibody array revealed that expression of eotaxin-3 (but not eotxin-1 and -2) was highly enhanced in MSCs treated with PC-3-conditioned medium. A gene expression array showed significantly increased expression of CCR3, a receptor of eotaxin-3, in PC-3. In a matrigel invasion assay, interferon-gamma, a specific inhibitor of eotaxin-related homing, significantly reduced the transmigration of PC-3 cells, under co-cultured condition with MSCs, in a dose-dependent manner (P < 0.05). Consistent with these results, anti-CCR3 antibody successfully reduced PC-3 migration under the co-cultured condition. These findings suggest that MSCs to modulation of the invasive potential of prostate cancer cells via the eotaxin-3/CCR3 axis.
Copyright © 2018 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  CCR3; Cancer microenvironment; Eotaxin-3; Homing chemokines; Mesenchymal stem cells

Mesh:

Substances:

Year:  2018        PMID: 30029937     DOI: 10.1016/j.prp.2018.06.012

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  6 in total

Review 1.  Consistent Inclusion of Mesenchymal Stem Cells into In Vitro Tumor Models.

Authors:  Luís P Ferreira; Vítor M Gaspar; João F Mano
Journal:  Methods Mol Biol       Date:  2021

2.  Cholesterol Is a Dose-Dependent Positive Allosteric Modulator of CCR3 Ligand Affinity and G Protein Coupling.

Authors:  Evan van Aalst; Benjamin J Wylie
Journal:  Front Mol Biosci       Date:  2021-08-20

3.  In Silico Identification of Cholesterol Binding Motifs in the Chemokine Receptor CCR3.

Authors:  Evan van Aalst; Jotham Koneri; Benjamin J Wylie
Journal:  Membranes (Basel)       Date:  2021-07-28

4.  Analysis of the signal cross talk via CCL26 in the tumor microenvironment in osteosarcoma.

Authors:  Masanori Kawano; Tatsuya Iwasaki; Ichiro Itonaga; Yuta Kubota; Kazuhiro Tanaka; Hiroshi Tsumura
Journal:  Sci Rep       Date:  2021-09-13       Impact factor: 4.379

5.  Effect of the Rehabilitation Program, ReStOre, on Serum Biomarkers in a Randomized Control Trial of Esophagogastric Cancer Survivors.

Authors:  Susan A Kennedy; Stephanie L Annett; Margaret R Dunne; Fiona Boland; Linda M O'Neill; Emer M Guinan; Suzanne L Doyle; Emma K Foley; Jessie A Elliott; Conor F Murphy; Annemarie E Bennett; Michelle Carey; Daniel Hillary; Tracy Robson; John V Reynolds; Juliette Hussey; Jacintha O'Sullivan
Journal:  Front Oncol       Date:  2021-09-15       Impact factor: 6.244

Review 6.  Fractalkine/CX3CL1 in Neoplastic Processes.

Authors:  Jan Korbecki; Donata Simińska; Klaudyna Kojder; Szymon Grochans; Izabela Gutowska; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Int J Mol Sci       Date:  2020-05-25       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.